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Abstract
This study aimed to characterize endometrial cancer regarding cancer stem cells (CSC) markers, regulatory and differentiation
pathways, tumorigenicity and glucose metabolism. Endometrial cancer cell line ECC1 was submitted to sphere forming proto-
cols. The first spheres generation (ES1) was cultured in adherent conditions (G1). This procedure was repeated and was obtained
generations of spheres (ES1, ES2 and ES3) and spheres-derived cells in adherent conditions (G1, G2 and G3). Populations were
characterized regarding CD133, CD24, CD44, aldehyde dehydrogenase (ALDH), hormonal receptors, HER2, P53 and β-
catenin, fluorine-18 fluorodeoxyglucose ([18F]FDG) uptake and metabolism by NMR spectroscopy. An heterotopic model
evaluated differential tumor growth. The spheres self-renewal was higher in ES3. The putative CSC markers CD133, CD44
and ALDH expression were higher in spheres. The expression of estrogen receptor (ER)α and P53 decreased in spheres, ERβ
and progesterone receptor had no significant changes and β-catenin showed a tendency to increase. There was a higher 18F-FDG
uptake in spheres, which also showed a lower lactate production and an oxidative cytosol status. The tumorigenesis in vivo
showed an earlier growth of tumours derived from ES3. Endometrial spheres presented self-renewal and differentiation capacity,
expressed CSC markers and an undifferentiated phenotype, showing preference for oxidative metabolism.
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Introduction
Cancer stem cells (CSC) are a minor population of tumour
cells which are capable of self-renewal, originating progenitor
cells that differentiate aberrantly and do not respond adequate-
ly to homeostatic controls. This is in agreement with the the-
ory of CSC which assumes the presence of a subpopulation
responsible for tumour maintenance, dissemination, and
recurrence [1].
The endometrium has a unique regenerative capacity that is
observed every menstrual cycle and in several periods of re-
productive life. Endometrial stem cells have been identified
considering clonogenic capacity, side population and label
retaining cells [2–4]. The evidence of CSC in endometrial
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cancer was associated with a functional profile and other char-
acteristics such as CSC markers [5]. Endometrial CSC were
described in primary endometrial carcinomas, identified by
their clonogenic capacity and presence of genes associated
with self-renewal [6]. The side population was also evaluated
in endometrial cancer cell lines and primary tumours,
representing 0.02–0.08% and 3.4% respectively. This minor
population presented self-renewal, enhanced migration,
lamellipodia and uropodia formation and tumorigenesis [7].
The side population was also associated with upregulation of
genes related to epithelial to mesenchymal transition (EMT)
[8].
CSC markers were already evaluated in endometrial tu-
mours, namely markers related to embryonic development
such asMUSASHI-1,NANOG andOCT4, and associated with
this phenotype [6, 9, 10]. Regarding CD133, a positive popu-
lation with self-renewal, it represented 5.7% to 27.4% in pri-
mary endometrial tumours and its expression was correlated
with the worst prognosis [11, 12]. Likewise, the ALDHhigh
population was associated with a worse prognosis in endome-
trial cancer with differentiation markers, such as CD9, being
absent in these cells [13].
Plasticity is another characteristic of CSC that is evident in
resistance to treatment. The resistance mechanisms related to
the endometrial CSC are influenced by the presence of ABC
efflux transporters, ALDH activity, resistance to DNA dam-
age, autophagy, resistance to apoptosis, activation of develop-
mental pathways and microenvironment stimuli [5, 14].
Regarding endometrial CSC side population, CD133+ popu-
lation showed decreased sensitivity to paclitaxel, doxorubicin
and cisplatin [11, 13].
A comprehensive analysis of cell populations derived from
an endometrial cancer cell line through a methodology involv-
ing a sphere forming protocol was performed, with respect to
expression of CSC markers, hormonal receptors, EMT differ-
entiation and metabolic profile. We also investigated the dif-
ferential tumorigenicity in vivo of tumorospheres and derived
adherent populations.
Materials and Methods
Cell Culture and Sphere-Forming Protocol
The human endometrioid carcinoma type I cell line (ECC-1)
obtained from American Type Culture Collection (ATCC) in
June 2012 was propagated in adherent conditions according to
recommendations at 37 °C and 5% CO2 in Rooswell Park
Memorial Institute 1640 Medium (RPMI 1640, Sigma R-
R6504) with 5% fetal bovine serum (Sigma F-7524),
400 μM sodium pyruvate (Gibco, 11360) and 1% antibiotic
(100 U/mL of penicillin and 10 μg/mL streptomycin; Sigma
A5955).
The sphere-forming protocol was adapted from previous
descriptions [15–17]. The ECC-1 cell line was cultured during
5 days inDulbecco’s Modified Eagle Medium and the mixture
of Ham’s F12 nutrients at a ratio of 1:1 (Sigma, DMEM-F12
D8900), supplemented with 100 μM putrescine (Sigma,
P7505), 1% insulin-transferrin-selenium-A (Gibco, 51300–
044) and 1% methylcellulose (Sigma, M7027) in suspension
culture appropriate flasks (Sarstedt 83.1813.502) or plates
(Costar, 3548), previously coated with poly(2-hydroxyethyl-
methacrylate) (Sigma, P3932). Every two days, basic fibro-
blast growth factor (bFGF, Sigma, F0291) and epidermal
growth factor (EGF, Sigma, E9644), both at a concentration
of 10 ng/mL, were added. On the fifth day, the first generation
spheres, named ES1, were obtained and cells were col-
lected for experiments or placed into standard culture
conditions as previously described for the ECC-1 cell
line. A monolayer of cells, named G1 (first generation
of adherent cells derived from the spheres), was obtain-
ed. After reaching cell confluence of 85–90% cells were
detached and collected for experiments or for repetition
of the sphere-forming protocol in order to obtain sec-
ondary sphere cultures, named ES2. This procedure was
repeated successively in order to obtain three spheres
(ES1, ES2 and ES3) and three adherent populations
(G1, G2 and G3).
Sphere-Forming Capacity, Self-Renewal, Cloning
Efficiency
In order to evaluate the capacity that each adherent cells
possesses to originate spheres, ECC-1, G1 and G2 cells
were cultured in sphere forming protocol conditions at a
concentration of 8 × 104 cells/mL. After five days, the
spheres with more than 40 μm in diameter were
counted.
To evaluate self-renewal (ability of sphere cells to originate
new colonies of spherical cells in suspension) cells isolated
from ES1, ES2 and ES3 were cultured in sphere-forming pro-
tocol conditions at a concentration of 8 × 104 cells/mL. After
eight days, the spheres with more than 40μm in diameter were
counted.
To access cloning efficiency (capacity of a cell to generate
an adherent colony of 50 or more cells) ECC-1, ES1, ES2,
ES3, G1, G2 and G3 were submitted to the clonogenic assay
as described [18]. The number of colonies was recorded
twelve days after platting.
Flow Cytometry
The expression of CD24, CD44 and CD133 in ECC-1, ES1,
ES2, ES3, G1, G2 and G3 was assessed using flow cytometry.
Suspensions of 106 cells in 100 μL of phosphate-buffered
saline (PBS; in mM: 137 NaCl, 2.7 KCl, 10 Na2HPO4, and
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1.8 KH2PO4 [pH 7.4]) were labelled with anti-CD24
(Beckman Coulter, PNIM2645), anti-CD44 (BioLegend,
103,020) and anti-CD133 (Miteny Biotec, 293C3-PCA)
according to the manufacturer’s recommendations.
Subsequently, cell suspensions were evaluated in a
FACS-Canto II flow cytometer (BD, San Jose, CAA) and
analysed with FACSDiva software (BD, San Jose, CA).
Western Blot
The expression of ALDH, β-catenin, HER2, oestrogen
receptor-α (ERα), oestrogen receptor-β (ERβ), progesterone
receptor (PR) and P53 was evaluated by western blot, as pre-
viously described [19]. Briefly, total protein extracts of ECC-
1, ES1, ES2, ES3, G1, G2 and G3 were prepared. After SDS-
PAGE proteins were electron-transfered to polyvinylidene
fluoride membranes. Incubation with primary antibodies was
performed overnight at 4 °C with constant stirring. For the
detection of proteins of interest the following antibodies were
used: anti-ALDH 1/2 H-8 (SC-166362, Santa Cruz
Biotechnology, Inc.), anti-β-actin (Sigma-Aldrich, A5316),
anti-β-catenin (Santa Cruz Biotechnology, Inc., sc7963),
anti-p53 DO7 (Santa Cruz Biotechnology, Inc., sc-47,698),
anti-ERα (Abcam, ab1104), anti-ERβ X-24 (Santa Cruz
Biotechnology, Inc., sc-133,554) and anti-SP2 PR (Abcam,
ab27161). Incubation with the appropriate secondary anti-
body, namely anti-mouse (GE Healthcare, RPN5781) or
anti-rabbit (Santa Cruz Biotechnology, Inc., sc-2007), was
performed at room temperature for about 1 h. The blots
were stained with fluorescent reagent elemental chlorine
free (ECF Western Blotting Reagent Pack, Amersham
Biosciences, UK) and developed in fluorescence scanner
(Typhoon 9000 FLA, Sweden). In cases where the elec-
trophoresis conditions do not provide retention of β-
actin in the gel the membranes were first stained with
Ponceau S (Sigma, P3504).
18F-FDG Uptake
18F-FDG uptake was evaluated in ECC1, ES1, ES2, ES3, G1,
G2 and G3 as previously described [20]. Cell suspensions
with 2 × 106 cells/mL were prepared and 925 Bq/mL of 18F-
FDGwas added to the cell culture medium. Five minutes after
addition of the radiotracer and over 120 min with a 30-min
interval, duplicate aliquots of 200 μL of cell suspension were
removed to eppendorf tubes containing cold PBS. The sam-
ples were then centrifuged at 5585 g for 60 s (Costar Spin
Mini) to separate pellet and supernatant, the latter having be-
ing collected to another test tube. Radioactivity of both frac-
tions (supernatant and pellet) was counted in a well scintilla-
tion counter (Capintec Inc., Model CRC - 15W) in counts per
minute (CPM) in order to determine the 18F-FDG uptake per-
centage by the cell populations.
NMR Spectroscopy
NMR isotopomer analysis of cell metabolism was performed
as previously described [21, 22]. The ECC1 cell line, ES1 and
G1 were cultured in the appropriate media but glucose was
replaced by its uniformly enriched 13C isotopomer ([U-13C]
glucose, Sigma, 389,374). After 24 h, the cultures were
washed with PBS and lysed with ice cold methanol H2O
80%:20% (v/v). The samples were centrifuged at 5725 g dur-
ing 5 min in order to separate the aqueous phase from the
pellet. After drying the aqueous phase, the resulting extracts
were dissolved in a solution of sodium fumarate (10 mM) in
D2O (99.9%). Culture medium samples were analysed adding
40 μL of the sodium fumarate D2O solution.
The 1H-NMR spectra were acquired in a 14.1 Tesla Varian
NMR spectrometer using a 3 mm indirect detection probe, and
consisted of 64 k points defining a spectral width of 7200 Hz.
A total of 16 scans were acquired, using a 30° radiofrequency
pulse and an interpulse delay of 10 s to ensure full relaxation.
The 13C-NMR spectra were acquired in the same spectrometer
but using a broadband 3 mm NMR probe, with waltz proton
decoupling. Each spectrum consisted of 128 K points defining
a spectral region of 35 kHz. To obtain a signal/noise
ratio compatible with metabolic analysis between
15,000 and 20,000 transients were acquired, using a
45° radiofrequency pulse of and interpulse delay of
3 s, to ensure full relaxation of the aliphatic carbons. The
analysis of the obtained 1H- and 13C-NMR spectra was carried
out using the software NUTSpro™ (Acorn NMR Inc.,
Livermore, CA).
Heterotopic Animal Model
The experimental protocol was approved by the Ethics
Committee of the Medicine Faculty of Coimbra University
(Ref: Of IBB/48/09). All experiments were performed in ac-
cordance with guidelines and regulations of the European
Union. The Balb/c nu/nu mice were inoculated with ECC-1,
ES1, ES2, ES3, G1, G2 and G3 (2 × 106 cells) into the dorsal
region by subcutaneous injection and the heterotopic tumour
growth was monitored weekly. Three animals per condition
were inoculated. When the xenografts reached a volume of
100 mm3, growth was monitored daily for 10 days. The ani-
mals were euthanized and the tumours were excised for the
histological study. The samples were fixed in buffered forma-
lin at a concentration of 10%, dehydrated in increasing alcohol
concentrations, cleared in xylene and embedded in paraffin. A
randommicrotome was performed and the slides were stained
with hematoxylin and eosin (H&E) for the characterization of
morphology, malignancy, degree of differentiation and pres-
ence of necrosis. Microscopic observation was performed on a
Nikon Eclipse 50i microscope equipped with digital camera
Nikon Digital Sight DS-Fil.
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Statistical Analysis
Statistical analysis was performed using IBM SPSS Statistics
version 20, central tendency and dispersion measures were
determined for descriptive analysis. For inferential analysis,
normal distribution of quantitative variables was evaluated
according to the Shapiro-Wilk’s test.
Comparison of sphere-forming capacity, self-renewal,
clonogenic efficiency, CD133, CD24 and CD44 expression
was performed by one-way ANOVAwhen normal distribution
and homogeneity of variances were present and by Kruskal-
Wallis otherwise. Results obtained by western blot, including
analysis of ALDH, ERα, ERβ, PR, HER2, p53 and β-catenin
expression, were compared using one sample Student’s t test,
comparing to the value 1. 18F-FDG uptake experimental
values obtained for each condition were fitted to an exponen-
tial model using OriginPro software (OriginLab Corporation,
Northampton, USA), version 8.0, according to Equation
Uptake (%) ¼ A∙ 1−eln 2ð Þ∙t=T50% , A, maximum uptake,
T50%, time to half of the maximum uptake. These parameters
were compared using the one-way ANOVA. For NMR stud-
ies, experimental concentration values of [U-13C]lactate for
each time-point were fitted by linear regression for each cell
population. Comparison of slopes was performed using one-
way ANOVA. Comparison of C3_Lactate/C3_Alanine,
C3_Lactate/C4_Glutamate, C4Q/C4D45 and C3_Glutamate/
C4_Glutamate ratios between cell populations was performed
using one-way ANOVA or Kruskal-Wallis, according to the
previous conditions. In in vivo studies, comparison of
time until tumour volume of 100 mm3 was obtained
and the tumour volume at the end of 10 days was per-
formed using one-way ANOVA or Kruskal-Wallis.
When appropriate, multiple comparisons were performed
using Bonferroni correction. A significance level of 5%
was considered for all comparisons.
Results
The sphere-forming protocol originated spherical colonies of
cells in suspension from ECC-1, G1, G2 and G3. The
spheres ES1, ES2 and ES3 had spherical morphology,
sometimes irregular, with surface projections of cells
with variable sizes, shown in Fig. 1a). Derived adherent
G1, G2 and G3 cells arose as proliferating cells that
migrated from the periphery of the spheres and originated
a confluent layer.
Sphere-Forming Capacity, Self-Renewal Capacity,
Cloning Efficiency
The spheres-forming capacity for the ECC-1 cell line to orig-
inate ES1was 2.22 ± 0.93%, for G1 to originate ES2was 2.54
± 1.05% and for G2 to originate ES3 was 2.40 ± 0.85%, as
shown in Fig. 1b). The self-renewal of spheres revealed
1.55 ± 0.63% for ES1 dissociation, 1.78 ± 1.06% for ES2
and 3.14 ± 1.61% for ES3, the latter being significantly higher
than the former (p = 0.002), as shown in Fig. 1c). Spheres had
a cloning efficiency lower than the ECC-1 cell line, 90.77 ±
14.26%, of 23.71 ± 8,49% (p < 0.001) for ES1, of 14.62 ±
6.66% (p < 0.001) for ES2 and of 14.42 ± 9.20% (p < 0.001)
for ES3. The derived adherent G1, G2 and G3 had a cloning
efficiency not significantly different from the ECC-1 cell line,
as shown in Fig. 1d).
CSC Markers
The mean fluorescence intensity (MFI) of CD133, shown in
Fig. 2a), revealed that expression in ES3 was significantly
higher than in ECC-1 (p = 0.048). The MFI of CD44,
shown in Fig. 2b), evidenced no alterations in the ex-
pression considering the populations studied. The MFI
for CD24, shown in Fig. 2c), highlighted that expres-
sion in ES1 was significantly higher than in ECC-1
(p = 0.006). Regarding ALDH expression, shown in
Fig. 2d), it was significantly augmented in ES1 (1.41 ± 0.25,
p = 0.014), ES2 (1.86 ± 0.46, p = 0.001) and ES3 (2.10 ± 0.46,
p = 0.004) compared to ECC-1. The ALDH expression in G1
(1.27 ± 0.26), G2 (1.36 ± 0.23) and G3 (1.27 ± 0.35) was not
significantly different from ECC-1.
Molecular Markers
P53 expression, shown in Fig. 3a), was significantly lower in
ES1 (0.46 ± 0.15, p = 0.006), ES2 (0.61 ± 0.19, p = 0.06) and
ES3 (0.55 ± 0.16, p < 0.001) compared to ECC-1. The P53
expression in G1 (0.97 ± 0.17), G2 (0.98 ± 0.15) and G3
(0.95 ± 0.19) was similar to ECC-1. β-catenin expression is
shown in Fig. 3b) and was evaluated in ES1 (1.27 ± 0.10),
ES2 (1.25 ± 0.24), ES3 (1.20 ± 0.05), G1 (0.71 ± 0.07), G2
(0.69 ± 0.12) and G3 (0.75 ± 0.06). For HER2 expression, rep-
resented in Fig. 3c), it was not possible to identify any mark-
ing band with the specific antibody used, therefore a whole
protein extract from MCF-7 cell line was used as positive
control. ERα expression, shown in Fig. 3d), was significantly
lower in ES1 (0.060 ± 0.20, p < 0,001), ES2 (0.36 ± 0.13,
p < 0.001)) and ES3 (0.63 ± 0.24, p = 0.042) compared
to ECC-1. However, no differences were found for G1
(0.94 ± 0.08), G2 (1.06 ± 0.25) and G3 (0.88 ± 0.21).
ERβ expression, shown in Fig. 3e), in ES1 (0.97 ± 0.20),
ES2 (1.15 ± 0.42), ES3 (1.05 ± 0.41), G1 (1.11 ± 0.47), G2
(1.08 ± 0.31) and G3 (1.02 ± 0.25) remained similar to ECC-
1. Likewise, PR expression, shown in Fig. 3f), in ES1 (0.94 ±
0.15), ES2 (1.23 ± 0.10), ES3 (1.06 ± 0.21), G1 (1.06 ± 0.17),
G2 (0.91 ± 0.11) and G3 (1.12 ± 0.13) was not significantly
different from ECC-1.
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Glucose Metabolism
The maximum 18F-FDG uptake, Fig. 4a), was higher in
spheres than in the parental cell line ECC-1 (0.55 ±
0.05%), with a value of 1.00 ± 0.05% (p = 0.0076) for
ES1, 0.98 ± 0.06% (p = 0.0062) for ES2 and 1.04 ±
0.09% (p = 0.018) for ES3. There were no differences
comparing ECC- 1 and adherent population, with max-
imum uptake of 0.54 ± 0.01% in G1, 0.55 ± 0.03% in
G2 and 0.66 ± 0.07% in G3.
The [U-13C] lactate production, whose expansion
spectra is represented in Fig. 4b), increased with incu-
bation time. The lactate production rate, Fig. 4c), de-
creased in ES1 in comparison with ECC-1 (p < 0.001)
and G1 (p < 0.001). The decrease in lactate output to the
culture medium was indicative of a lower glycolytic
activity in ES1. The 13C-NMR spectra, showed that
the C3_Lactate/C3_Alanine ratio, represented in Fig.
4d), in ES1 (3.13 ± 1.61) was inferior to G1 (12.08 ±
6.52, p = 0.022) and to ECC-1 (10.48 ± 2.32), pointing
to an increased cytosolic oxidized state in ES1. The
C3_Lactate/C4_Glutamate ratio, shown in Fig. 4e), was
lower in ES1 (7.52 ± 2.69) than ECC-1 (15.73 ± 1.27,
p = 0.038) and G1 (16.34 ± 4.79), indicating a higher
coupling between glycolysis and Krebs cycle in ES1.
The Krebs cycle turnover, evaluated by the C4Q/
C4D45 ratio, presented in Fig. 4f), remained similar
comparing ECC-1, ES1 and G1. Similarly, in the
G3
ES1 ES2
G2
ES3
ECC1
G1
a
b c d
Fig. 1 a ECC-1 cell line, sphere populations (ES1, ES2 and ES3) and
derived adherent populations (G1, G2 and G3). The arrows represent the
succession of obtaining cell cultures. Images were obtained with a mag-
nification of 400x. b Sphere-forming capacity of ES1, ES2 and ES3
expressed as the ratio between the number of spheres and the number
of cells distributed. Results represent the mean and standard error of six
experiments; there were no significant differences among populations. c
Self-renewal of ES1, ES2 and ES3 expressed as percentage of the ratio
between the number of spheres obtained and the number of cells
distributed. Results represent the mean and standard error of six
experiments. d Cloning efficiency of ECC-1, ES1, ES2, ES3, G1,
G2 and G3 expressed as the ratio between the number of colonies
and the number of cells distributed. Results represent the mean
and standard error of at least six experiments. The significant
differences were represented with ** for p < 0.01 and *** for p < 0.001
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Fig. 2 a CD133, b CD24 and c CD44 expression using flow
cytometry in ECC-1, ES1, ES2, ES3, G1, G2 and G3. The
graphs express the MFI and standard error of at least three
experiments. d) ALDH expression in ECC-1, ES1, ES2, ES3,
G1, G2 and G3. The results are presented as the ratio of the
fluorescence intensities of ALDH and β-actin and the graphs
represent the variation in relation to the expression of ECC-1 cell
line (ALDH/β-actin equal to 1). The values presented express the
mean and standard error of at least four experiments. The images repre-
sent an immunoblot of ALDH and β-actin expression for each experi-
mental condition. The significant differences were represented with * for
p < 0.05 and ** for p < 0.01
ECC1   |   ES1   |    ES2   |   ES3   |   G1   |   G2   |   G3   |  MCF7   
a b c
d e f
Fig. 3 a P53, bβ-catenin, cHER2, d ERα, e ERβ and f PR expression in
ECC-1, ES1, ES2, ES3, G1, G2 and G3. The results are presented as the
ratio of the fluorescence intensities of P53, β-catenin, ERα, ERβ and PR
versus actin and the graphs represent the alteration in relation to the ECC-
1 cell line (protein of interest/β-actin equal to 1). The values presented
express the mean and standard error of at least four experiments.
Significant differences from ECC-1 cell line were represented with *
p < 0.05, ** p < 0.01 and *** p < 0.001. The images represent an immu-
noblot of P53, β-catenin, ERα, ERβ and PR and actin expression for
each experimental condition. c Representative immunoblot of HER2 ex-
pression in the ECC-1 cell line, ES1, ES2, ES3, G1, G2 and G3.
The MCF-7 cell line was used as positive control. Below is rep-
resented an image of the same membrane previously submitted
staining with Ponceau
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C3_Glutamate/C4_Glutamate ratio, shown in Fig. 4g),
no significant differences were found between the
populations.
The Fig. 5a) represents an example of animals from
each group monitored weekly after obtaining a tumour
volume of 100 mm3. The evaluation of tumour growth
points to an earlier onset of tumours in ES3 xenotrans-
plantation, identified in the first week. The resulting
tumours from ECC-1 (37.8 ± 9.9 days) and G1 (40.0 ±
1.4 days) were those which took longer to reach a vol-
ume of 100 mm3. On the contrary, ES3 cells originated
this volume in only 3.7 ± 1.2 days.
The same outcome for ES1 was 27.5 ± 15.2 days, for ES2 it
was at 23.8 ± 9.0 days, for G2 itwas at 24.5 ± 4.5 days and for
G3 4.7 ± 2.1 days, thus not showing any statistically significant
differences. Considering the relative tumour volume in the
10 days after reaching 100 mm3, shown in Fig. 5b), the growth
was superior for ES2 (4.50 ± 0.64) and ES3 (4.26 ± 0.32); how-
ever, the growth pattern was not significantly different from
ECC-1 (2.71 ± 0.20), ES1 (2.89 ± 0.45), G1 (3.73 ± 0.79), G2
(3.14 ± 1.30) and G3 (2.66 ± 1.16). The histological study, rep-
resented in Fig. 6 revealed that the xenografts correspond to
malignant epithelial tumors with similar characteristics to each
other, consisting mainly of solid areas with glandular tissue in
a minor proportion. The cells are polygonal, with eosinophilic
cytoplasm and pleomorphic hyperchromatic nuclei. There are
mitoses, atypia and necrotic areas.
Discussion
This experimental study evaluated the spheres of endometrial
cancer cells and the derived adherent cells which had the ca-
pacity to differentiate in the original phenotype. Studies based
on sphere protocol have been largely used to evaluate the
activity of normal and tumour stem cells [1, 23]. This popu-
lation was described for various solid tumours, particularly for
breast cancer, prostate cancer, colorectal cancer, gliomas, pan-
creatic cancer, hepatocellular carcinoma and lung cancer [1].
The model of tumorospheres allows the study of CSC and has
been applied in various fields such as the evaluation of tumour
growth, stemness, tumorigenicity in vivo and sensitivity to
drugs. The supplementation with bFGF and EGF ensures the
maintenance of spheres and other stem cells, including embry-
onic stem cells, are not fully understood. Regarding bFGF, it
regulates the level and post-transcriptional state of several
target molecules affecting cell self-renewal, cell survival, cell
proliferation, cell adhesion and suppression of terminal differ-
entiation [24]. In the sphere-forming protocol, each sphere is
derived from the clonal growth of a single cell being distrib-
uted at low density in semisolid media to prevent cell fusion
and aggregation [15]. This inhibition of cell adhesion causes
the death of differentiated cells by anoikis [25]. The sphere-
forming protocol was repeated successively from cultures of
adherent populations derived from spheres. The successive
sphere-forming protocol reflects the self-renewal capacity.
ECC-1 ES1
24h
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G1
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1.430 1.420 1.410 1.400 1.390 1.430 1.420 1.410 1.400 1.390 1.420 1.410 1.400 1.390
a
d e f g
b c
Fig. 4 a 18F-FDG uptake in ECC-1, ES1, ES2, ES3, G1, G2 and G3. The
values express the mean and standard error of the uptake percentage at 5,
30, 60, at 90 and 120 min of at least 4 experiments, R2 > 0.95 for all
groups. b Expansions of 1H-NMR spectra of the culture medium of
ECC-1 cells, ES1 and G1 relating to one of the satellites of [U-13C]
lactate. Resonance is composed of six peaks, resulting from the existence
of homo couplings (3JHH) and heteronuclear (
2JHC e
3JHC). Samples were
referring to 0, 1, 4, 8, 12 and 24 h. c Concentration of [U-13C] lactate in
the culture medium during 24 h incubation for ECC- 1, ES1 and G1
populations. The values presented express the average and standard error
of at least four experiments, for each time. The slope (mM/h) for ECC-1 it
was 0.57 ± 0.02 (r2 = 0.93), for ES1 was 0.30 ± 0.01 (r2 = 0.91) and for
G1 was 0.51 ± 0.02 (r2 = 0.92). d) C3_lactate/C3_alanin ratio, e C3_
Lactate/C4_glutamate ratio, f C4Q/C4D45 ratio and g) C3_ glutamate/
C4_glutamate ratio for ECC-1, ES1 and G1. The values presented ex-
press the mean and standard error of at least four experiments. Significant
differences from ECC-1 cell line were represented with * p < 0.05
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Other authors observed self-renewal and differentiation of
spheres, addressing its plasticity [26].
The sphere-forming capacity previously showed an appar-
ently specific variability of each line [27]. The self-renewal
capacity indicates that the sphere population is heterogeneous,
with a small proportion of cells with symmetric division ca-
pacity. In our study, the increase in self-renewal capacity be-
tween ES1 and ES3 may be indicative of a subsequent enrich-
ment of stemness properties. The clonogenic efficiency ob-
tained in our experimental study showed a lower ability to
form colonies in spheres compared with the ECC-1 cell line
and adherent populations. Thus, this suggests the need for a
period of adaptation prior to switching to adherent conditions,
while confirming the plasticity of the spheres population [28].
In our study, CD133 expression was higher in spheres
ES1, ES2 and ES3, particularly regarding the latter, which
may also be indicative of enhanced stemness. Studies with
tumorospheres from other tumours reported a higher percent-
age of CD133+ superior than monolayer culture [29, 30]. Our
study showed a higher expression of CD44 in spheres, signif-
icant in ES1 and values of adherent populations, consistent
with the loss of CD44 expression with differentiation.
Previous studies on CSC showed high levels of ALDH sug-
gesting that ALDH activity may be a common marker for the
Week 1
Week 2
Week 3
Week 4
Week 5
Week 6
ECC-1 ES1 ES2 ES3 G1 G2 G3
10 days
a
b
Fig. 5 a Illustrative photographic
record of tumour growth after
obtaining a volume of 100 mm3.
b Tumour growth of ECC-1, ES1,
ES2, ES3, G1, G2 and G3. The
values presented express the
mean and standard error of at least
three experiments; the results
express the relative tumour
volume (tumour volume/
100 mm3)
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stem cell population in normal and malignant tissue [31].
ALDH expression was associated with spheres of other types
of cancer, including ovary, colorectal and neuroblastoma [30,
32] . These studies also showed decreased ALDH expression
with differentiation into adherent conditions.
In breast and lung tumours, P53 reduced CD44 ex-
pression by inhibiting transcription, which resulted in
decreased tumorigenicity [33]. In our study the decrease
of P53 in spheres was accompanied by an increase in
CD44 expression which correlates with the loss of P53
repression. β-catenin expression in spheres showed an
increasing trend compared to ECC-1. Other studies with
CSC had increased β-catenin activity [29, 34]. The
WNT/β-catenin pathway regulates endometrial prolifera-
tion and differentiation and is activated in endometrial
carcinoma [35]. In association, the decrease in ERα
expression in endometrial spheres, observed in our
study, may have implications for activation not only of
the WNT pathway but also of the PI3K/AKT/mTOR
pathway also involved in cell proliferation and survival.
In the initial stage of endometrial repair the epithelial cells
do not express ERα which are only expressed during prolif-
eration and differentiation phase of epithelial glandular cells
and to a lesser extent, in stromal cells [36] . The loss of ERα
was accompanied by an increase in ALDH, and was corrobo-
rated by other authors who reported endometrium tumour
cells with ALDH expression being ER negative [13].
Thus, the loss of these receptors might reveal a more
undifferentiated phenotype and relate to EMT in
hormone-dependent tumours. Spheres, where decreased
a b
c d 
g h
k l
e f
i j
m n
Fig. 6 Histological images representative of heterotopic tumours stained
with hematoxylin and eosin from animals injected with ECC-1 (a and b),
ES1 (c and d), G1 (e and f) ES2 (g and h), G2 (i and j), ES3 (k
and l), G3 (m and n). Histological images represent predominantly
solid tumours with a minor glandular component. The cells have
high cytonuclear atypia, high mitotic index and some areas of
necrosis. For each pair of images, the left has a magnification
of 40x and the right of 200x
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α isoform was observed, maintain the β isoform expression
which may be responsible for a proliferation-promoting effect
on these cells [37].
The spheres´ increased 18F-FDG uptake may be explained
by the lower expression of P53 since the uptake of this radio-
pharmaceutical is dependent on its function [38]. The
Warburg effect, which defines the dependence of cancer on
fermentative glycolysis, is required for tumour cells to resist
oxidative stress and be able to adapt to hypoxia conditions.
This metabolic shift may be an early or late event or be a
genetically determined dysfunction or induced by metabolic
changes [39]. The intracellular fate of glucose was evaluated
in further detail by monitoring the incorporation of 13C into
metabolic intermediates resulting from [U-13C]glucose me-
tabolism in ECC-1, ES1 and G1. The [U-13C]lactate produc-
tion was lower over 24 h in ES1 compared to ECC-1 and G1,
which indicates the preferential use of fermentative glycolysis
by ECC-1 and G1. Moreover, the redox state in the cytosol,
inferred by the relationship C3_Lac/C3_Ala, was lower in
ES1 compared to ECC-1. The coupling of the glycolytic path-
way to the Krebs cycle was increased in ES1 compared to
ECC-1 and G1, allowing a more complete oxidation of gly-
colytic intermediates. There are some studies that associate the
metabolism of CSC to fermentative glycolysis instead of mi-
tochondrial oxidative phosphorylation [40]. However, other
studies have indicated a metabolic state associated with oxi-
dative phosphorylation, unlike the Warburg effect [41]. Our
results suggest that in CSC of endometrial origin oxidative
phosphorylation assumes more relevance and that a higher
avidity for glucose is also present, compared to the parental
cell line.
The relative tumour volume was higher in ES3 and
ES2, which points to a greater capacity for initiation
and maintenance of tumour growth. In another study
of endometrial cancer, tumorospheres also had larger
tumours than differentiated cells [10]. Also, the
CD133+ population from a human endometrial tumours
was more tumorigenic than the main population [12].
These data are consistent with the presence of a popu-
lation of CSC with tumorigenic capacity in vivo.
Tumorospheres are not a homogeneous structure of
undifferentiated cells but include a variability of mor-
phologically distinct entities with molecular heterogene-
ity inter- and intrasphere. The sphere protocol selective-
ly enriches the CSC growth, albeit also progenitor cells
and differentiated tumour cells [25]. In fact, the aim of
successively repeating the protocol was to isolate a
group of cells with the highest prevalence of stem prop-
erties, as well as checking the maintenance of self-
renewal properties. The enhanced stemness of ES3 was
emphasized by higher self-renewal, CD133 and ALDH
expression and tumorigenicity in vivo than the first
sphere generation. Globally, these and the other findings
of this work, namely, stem cell markers and molecular
markers of differentiation, suggest an analogous profile
and highlight spheres with CSC properties compared to
adherent populations.
This experimental work used a successive sphere protocol
in endometrial cancer that isolated a late generation (ES3)
with higher stemness properties considering self-renewal ca-
pacity, CD133 expression and tumorigenicity. Generally, the
spheres had higher expression of CSC markers, namely
CD133, CD44 and ALDH and tumorigenicity in vivo than
adherent populations. A more undifferentiated phenotype, re-
vealed by a decrease in ERα, the decrease in P53 expression
and the activation of β-catenin pathway, were associated with
the spheres´ phenotype. Furthermore, the glucose metabolism
in spheres revealed an increased uptake associated with com-
plete oxidation instead of the Warburg effect, which is more
globally associated with cancer populations. The strategy used
to isolate CSC pointed to a population with a molecular and
metabolic profile suitable to be used in the future as a model
for other studies such as research of tumour markers and
targeted therapies.
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